University of Dundee

Latest News

July 2019

  • The VEXed Trypanosome. Image courtesy of Joana Faria
    09 Jul 2019

    A team of scientists at the School of Life Sciences have identified a protein that makes random decisions to allow parasites to survive in their human hosts. They have been able to identify a complex that allows genes to switch on and off randomly, changing cell surface characteristics and allowing escape from the defences of the host’s immune system. This behaviour is present in genes within parasites known as trypanosomes, and also in the parasite that causes malaria, which claims hundreds of thousands of lives every year.

  • Professor Alessio Ciulli
    08 Jul 2019

    The University of Dundee has announced a new partnership with Eisai, one of the world’s leading research-based pharmaceutical companies, aiming to create innovative new drugs for the cancer field. The collaboration combines the world-leading PROTACs expertise and technology of Professor Alessio Ciulli from the Division of Biological Chemistry and Drug Discovery in the School with Eisai’s discovery research and clinical development experiences in oncology.

  • 05 Jul 2019

    This week has seen two major announcements made on projects that Open Microscopy Environment (OME), led by Professor Jason Swedlow in the School, have collaborated on: 1. Euro-BioImaging European Research Infrastructure Consortia The UK will be joining the Euro-BioImaging European Research Infrastructure Consortia, hosted in Finland, as a founder member. OME has participated in Euro-BioImaging since its inception and has led its efforts to build public resources for imaging data.

  • Undergraduate students in lab practical class
    03 Jul 2019

    The University of Dundee has been ranked 4th among UK universities for overall student satisfaction in the 2019 National Student Survey (NSS). The University recorded overall satisfaction of 90%, up 2% on the 2018 result and well above the sector average of 84%, and was ranked 2nd in Scotland.

  • 03 Jul 2019

    The Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson’s disease. This announcement builds upon existing drug discovery partnerships the DDU has with Takeda and GSK. Parkinson’s disease is the second most common neurological disorder, after Alzheimer’s disease, affecting around two people in every 1000 across the population. There are around 6.1 million people worldwide and 120,000 people in the UK living with the condition.

  • Professor Sir Mike Ferguson
    02 Jul 2019

    Mike Ferguson, Regius Professor of Life Sciences at the University of Dundee, has today received a knighthood for his services to science. Professor Sir Mike, one of the UK’s most eminent life scientists, received the award at Holyrood on Tuesday 2 July after his accolade was announced in the most recent New Year’s Honours list.

  • Margarita Kalamara and Tom Snelling
    02 Jul 2019

    Two PhD students in the School have been selected to join Europe’s finest University students in creative and intellectual collaboration at Roche Continents 2019. The highly prestigious Roche Continents - a full week of interdisciplinary challenges and inspiration – selects only 100 students from the sciences and arts at European Universities to attend. Tom Snelling from Philip Cohen's Lab (MRC-PPU) and Margarita Kalamara from Nicola Stanley-Wall’s Lab (Molecular Microbiology) are two of those who will take part in the week of activities in Salzburg in August.

June 2019

  • Dr Samantha Budd Haeberlein with Professors Miratul Muqit and Dario Alessi
    21 Jun 2019

    The University of Dundee has today awarded an Honorary Doctorate to Dr Samantha Budd Haeberlein who is Vice President of Late Stage Clinical Development at Biogen. Samantha is a distinguished graduate of Dundee having obtained a First Class Honours Degree in Biochemistry in 1994 and then completing a PhD in 1997 under the supervision of David Nicholls FRS on the bioenergetics of neurons. Since then Samantha has flourished in the pharmaceutical industry over the last 20 years and emerged as a global leader in developing effective therapies against Alzheimer’s disease.

  • 19 Jun 2019

    The University of Dundee is one of the world’s top 100 universities for research quality, according to a major survey released today (June 19).

  •  Ian Kelsall and Jiazhen Zhang
    18 Jun 2019

    About 10 years ago, the discovery of the Linear Ubiquitin Assembly Complex (LUBAC) revolutionized our understanding of how the master transcription factor NF-kB was activated.  LUBAC a complex of the three proteins, HOIP, HOIL-1 and Sharpin, produces unique “linear” ubiquitin chains in which ubiquitins are joined to each other by peptide bonds.

Pages